CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PATENT ANALYSIS
3.3.1. Patent analysis, by year
3.3.2. Patent analysis, by country
3.4. TOP IMPACTING FACTORS
3.4.1. Drivers
3.4.1.1. Rise in healthcare expenditure
3.4.1.2. Increase in R&D investments
3.4.1.3. Growth in proteomics research
3.4.2. Restraints
3.4.2.1. Lack of skilled professionals
3.4.3. Opportunities
3.4.3.1. Training the professionals
3.4.3.2. Greater potency with reduced costs and increasing affordability
CHAPTER 4 GLOBAL PROTEIN LABELING MARKET, BY LABELING METHOD
4.1. OVERVIEW
4.1.1. Market size & forecast
4.1.2. In vitro labeling
4.1.2.1. Market size & forecast
4.1.2.2. Nanoparticle labeling
4.1.2.2.1. MARKET SIZE & FORECAST
4.1.2.3. Site-specific Labeling
4.1.2.3.1. MARKET SIZE & FORECAST
4.1.2.4. Dye-based
4.1.2.4.1. MARKET SIZE & FORECAST
4.1.2.5. Co-translational labeling
4.1.2.5.1. MARKET SIZE & FORECAST
4.1.2.6. Enzymatic Labeling
4.1.2.6.1. MARKET SIZE & FORECAST
4.1.3. In vivo labeling
4.1.3.1. Market size & forecast
4.1.3.2. Radioactive labeling
4.1.3.2.1. MARKET SIZE & FORECAST
4.1.3.3. Photoreactive labeling
4.1.3.3.1. MARKET SIZE & FORECAST
4.1.4. Bioorthogonal labeling
4.1.4.1. Market size & forecast
CHAPTER 5 GLOBAL PROTEIN LABELING MARKET, BY APPLICATION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.1.2. Cellbased assays
5.1.2.1. Key market trends
5.1.2.2. Key growth factors and opportunities
5.1.2.3. Market size and forecast
5.1.3. Fluorescence microscopy
5.1.3.1. Key market trends
5.1.3.2. Key growth factors and opportunities
5.1.3.3. Market size and forecast
5.1.4. Mass spectrometry
5.1.4.1. Key market trends
5.1.4.2. Key growth factors and opportunities
5.1.4.3. Market size and forecast
5.1.5. Immunological techniques
5.1.5.1. Key market trends
5.1.5.2. Key growth factors and opportunities
5.1.5.3. Market size and forecast
5.1.6. Protein microarray
5.1.6.1. Key market trends
5.1.6.2. Key growth factors and opportunities
5.1.6.3. Market size and forecast
CHAPTER 6 GLOBAL PROTEIN LABELING MARKET, BY PRODUCT TYPE
6.1. OVERVIEW
6.1.1. Market size & forecast
6.2. KITS
6.2.1. Market size & forecast
6.3. REAGENTS
6.3.1. Market size & forecast
6.3.2. Enzymes
6.3.2.1. Market size & forecast
6.3.3. Monoclonal antibodies
6.3.3.1. Market size & forecast
6.3.4. Probes/Tags
6.3.4.1. Market size & forecast
6.3.5. Proteins
6.3.5.1. Market size & forecast
6.3.6. Other Reagents
6.3.6.1. Market size & forecast
6.4. SERVICES
6.4.1. Market size & forecast
CHAPTER 7 GLOBAL PROTEIN LABELING MARKET, BY END USERS
7.1. OVERVIEW
7.1.1. Market size & forecast
7.2. RESEARCH LABORATORIES
7.2.1. Market size & forecast
7.3. HOSPITALS AND DIAGNOSTIC CENTERS
7.3.1. Market size & forecast
7.4. OTHERS
7.4.1. Market size & forecast
CHAPTER 8 GLOBAL PROTEIN LABELING MARKET, BY GEOGRAPHY
8.1. OVERVIEW
8.1.1. Market size & forecast
8.2. NORTH AMERICA
8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size & forecast
8.2.4. U.S.
8.2.5. Canada
8.2.6. Mexico
8.3. EUROPE
8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size & forecast
8.3.4. Germany
8.3.5. France
8.3.6. UK
8.3.7. Rest of Europe
8.4. ASIA-PACIFIC
8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size & forecast
8.4.4. Japan
8.4.5. China
8.4.6. Australia
8.4.7. India
8.4.8. Rest of Asia-Pacific
8.5. LAMEA
8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size & forecast
8.5.4. Brazil
8.5.5. Republic of South Africa
8.5.6. Rest of LAMEA
CHAPTER 9 COMPANY PROFILES
9.1. GENERAL ELECTRIC COMPANY
9.1.1. Company overview
9.1.2. Operating business segments
9.1.3. Business performance
9.1.4. Key strategic moves & developments
9.2. PERKINELMER, INC.
9.2.1. Company overview
9.2.2. Operating business segments
9.2.3. Business performance
9.2.4. Key strategic moves & developments
9.3. THERMO FISHER SCIENTIFIC, INC.
9.3.1. Company overview
9.3.2. Operating business segments
9.3.3. Business performance
9.3.4. Key strategic moves & developments
9.4. MERCK & CO., INC.
9.4.1. Company overview
9.4.2. Operating business segments
9.4.3. Business performance
9.4.4. Key strategic moves & developments
9.5. F. Hoffmann-La Roche AG
9.5.1. Company overview
9.5.2. Operating business segments
9.5.3. Business performance
9.5.4. Key strategic moves & developments
9.6. KANEKA CORPORATION
9.6.1. Company overview
9.6.2. Operating business segments
9.6.3. Business performance
9.6.4. Key strategic moves & developments
9.7. PROMEGA CORPORATION
9.7.1. Company overview
9.7.2. Operating business segments
9.7.3. Business performance
9.7.4. Key strategic moves & developments
9.8. LI-COR, INC.
9.8.1. Company overview
9.8.2. Operating business segments
9.8.3. Business performance
9.8.4. Key strategic moves & developments
9.9. NEW ENGLAND BIOLABS, INC.
9.9.1. Company overview
9.9.2. Operating business segments
9.9.3. Business performance
9.9.4. Key strategic moves & developments
9.10. SERACARE LIFE SCIENCES, INC.
9.10.1. Company overview
9.10.2. Operating business segments
9.10.3. Business performance
9.10.4. Key strategic moves & developments
The other companies in the protein labeling market include:
Qiagen N.V.
Active Motif, Inc.
Takara Bio USA, Inc.
Candor Bioscience GMBH
Innova Biosciences Ltd.
Luminex Corporation
Bio-Rad Laboratories
Agilent Technologies, Inc.
Caprion Biosciences
Nanotemper Technologies GMBH
Biotium, Inc.
*Profiles of these players are not included. The same will be included on request.